Journal Menu
► ▼ Journal Menu-
- Biomedicines Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
13 December 2023
Prof. Dr. Felipe Fregni Appointed Editor-in-Chief of Biomedicines
We are pleased to announce that Prof. Dr. Felipe Fregni has been appointed Editor-in-Chief of Biomedicines (ISSN: 2227-9059).
Name: Prof. Dr. Felipe Fregni
Homepage: https://www.hsph.harvard.edu/ecpe/faculty/felipe-fregni/
Affiliation: 1.Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; 2.Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
Interests: neuromodulation; pain perception modulation; neurophysiology; neuroplasticity
Prof. Dr. Fregni is a Professor of epidemiology at Harvard T.H. Chan School of Public Health and PM&R at Harvard Medical School. He leads a large clinical research laboratory (Spaulding Neuromodulation Center) funded by major NIH grants and is currently investigating techniques to guide and measure neuroplasticity in brain injury. He has been at the forefront of advancing neurorehabilitation science to treat conditions such as stroke, Parkinson’s disease, and chronic pain. He holds an M.D. and Ph.D. from the University of Sao Paulo, Brazil, and three master’s degrees from Harvard University. He has more than 580 peer-reviewed publications and has been leading the international training program Principles. In recognition of his outstanding contributions, he has been awarded the highest honor bestowed by the United States government to outstanding scientists and engineers in the U.S.: the Presidential Early Career Award for Scientists and Engineers (PECASE).
Currently, his research focuses on understanding neuroplastic changes associated with conditions such as chronic pain, Parkinson’s disease, and stroke, using non-invasive brain stimulation as an investigative tool for such aims.
We warmly welcome our new Editor-in-Chief and wish the journal every success in the future.